Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis
Condition(s):Multi-drug Resistant TuberculosisLast Updated:November 4, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Multi-drug Resistant TuberculosisLast Updated:November 4, 2022Recruiting
Condition(s):Helicobacter Pylori InfectionLast Updated:August 15, 2018Completed
Condition(s):HealthyLast Updated:January 29, 2013Completed
Condition(s):Helicobacter Pylori Infection; Antimicrobial Susceptibility TestingLast Updated:April 25, 2017Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:June 26, 2012Completed
Condition(s):Dry EyeLast Updated:July 15, 2019Completed
Condition(s):Osteomyelitis – FootLast Updated:May 16, 2022Not yet recruiting
Condition(s):MDR-TBLast Updated:October 30, 2020Completed
Condition(s):Ceftolozane/Tazobactam; Imipenem/Relebactam; Hematology and OncologyLast Updated:December 12, 2019Unknown status
Condition(s):Retinal Detachment; Achilles Tendon; Aneurysm, DissectingLast Updated:July 6, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.